新体育(00299.HK)完成配售3.79亿股净筹1.705亿港元
格隆汇6月24日丨新体育(00299.HK)发布公告,载于认购协议所有认购事项先决条件已经达成,而认购事项已于2019年6月24日完成。公司已根据一般授权向认购人按认购价每股认购股份0.45港元配发及发行合共3.79亿股股份。
扣除相关开支后,认购事项所得款项净额约为1.705亿港元。公司将认购事项所得款项净额用于一般营运资金拨资。
紧随认购事项完成后及于公告日期,公众人士持有1,023,044,597股股份,占公司已发行股本总数约30.82%。因此,已恢复上市规则第8.08(1)(a)条公司已发行股本总额25%最低公众持股量的规定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.